Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

bioAffinity Technologies (BIAF) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareDiagnostics & ResearchBIAF

Get BIAF alerts
Open-market purchases1 insider$1.0M · last 12 months
Insiders selling1last 12 months
Reported sales$1.2M0 of 11 recent sales pre-planned (10b5-1)
In 15 seconds

Insiders put their own money in: $1.0M of open-market buys against $1.2M of sales. See how similar setups did below.

Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
Latest open-market trade

Sale HRT Financial LP, 10% Owner sold 41,529 shares at $6.45 ($268K).

Trade date
Oct 1, 2026
Disclosed to the SEC
Nov 19, 2026
Type
Sale (code S)

Read the original SEC filing ↗All BIAF insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

BIAF insider transactions (Form 4)

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Nov 19SEC HRT Financial LP10% Owner Sell 41,529116,658 held (−26%) $6.45 $268K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 30,065131,221 held (+30%) $7.67 $231K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 27,246131,221 held (−17%) $7.75 $211K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 18,929126,519 held (+18%) $8.59 $163K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 20,432126,146 held (−14%) $6.76 $138K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 18,627134,741 held (−12%) $6.83 $127K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 17,873116,658 held (+18%) $6.54 $117K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 13,856127,533 held (−10%) $7.57 $105K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 13,840134,741 held (+11%) $7.12 $99K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 11,002128,884 held (+9%) $8.14 $90K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 11,129128,884 held (−8%) $7.94 $88K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 10,859128,884 held (−8%) $8.11 $88K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 12,125126,146 held (+11%) $6.78 $82K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 10,734127,533 held (+9%) $7.64 $82K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 9,111126,037 held (−7%) $7.86 $72K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 7,077126,519 held (−5%) $8.63 $61K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 8,894134,741 held (+7%) $6.86 $61K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 7,509128,884 held (+6%) $7.91 $59K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 7,271126,037 held (+6%) $7.81 $57K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 2,201134,741 held (−2%) $7.05 $16K — 0
Nov 19SEC HRT Financial LP10% Owner Sell 152127,533 held (−0%) $8.10 $1K — 0
Nov 19SEC HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P Buy 2127,533 held (+0%) $8.09 $16 — 0
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for BIAF's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with BIAF in the Research Lab

Pre-set to BIAF's latest insider buy of $10K or more (Nov 19, 2026: HRT Financial LP, $1.0M). Tap to change anything.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

BIAF closeInsider buyInsider sale

Price history unavailable.

Bought, 12 months$1.0M
Sold, 12 months$1.2M
Insiders buying1
Insiders selling1

bioAffinity Technologies insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $1.0M and 1 sold $1.2M of BIAF stock on the open market.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this

BIAF insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $923K bought (10 trades)$923KQ3 2026: $907K sold (10 trades)Q3 2026Q4 2026: $117K bought (1 trades)$117KQ4 2026: $268K sold (1 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026$117K1$268K1
Q3 2026$923K10$907K10

Valuation, profit and volume

P/E (trailing)Not meaningful (no profit)Sector median 25.0
Market value$3.2MDiagnostics & Research
Profit margin-278.9%Revenue growth -26.0%

Source: Yahoo Finance, as of Nov 20, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 1 bioAffinity Technologies, Inc. insider reported open-market purchases totaling $1.0M, while 1 insider reported sales totaling $1.2M. Among insiders with enough purchase history to measure, HRT Financial LP (10% Owner) has the highest Insider Score at 0. 0 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

BIAF stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

What happened after BIAF insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Nov 19, 2026HRT Financial LP10% Owner$1.0M pendingpendingpending

Insiders at bioAffinity Technologies, Inc.

InsiderBoughtSoldLast filingPast buys beat S&PScore
HRT Financial LP10% Owner $1.0M $1.2M Nov 19, 2026 0 of 8 0

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

BIAF stock: common questions

Are bioAffinity Technologies, Inc. insiders buying BIAF stock?

In the past 12 months, 1 insider reported open-market purchases of BIAF worth $1.0M. The latest was 10% Owner Hrt Financial Lp bought $231K of BIAF at $7.67 — largest purchase by this insider in our records; raises the stake by 30%.

Are bioAffinity Technologies, Inc. insiders selling BIAF stock?

1 insider reported sales worth $1.2M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.